Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Home
Experts
Research units
Cores
Projects
Research output
Prizes
Search by expertise, name or affiliation
Current and future therapies for myasthenia gravis
Qing Yi
, Ann Kari Lefvert
Dr. Mary and Ron Neal Cancer Center
Academic Institute
Department of Medicine
Houston Methodist
Weill Cornell Medical College
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current and future therapies for myasthenia gravis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Myasthenia gravis
100%
Immune System
40%
Immunotherapy
20%
Immunosuppression
20%
Autoantibody
20%
Autoimmunity
20%
Immunity
20%
Autoimmune Disease
20%
Neuromuscular Junction
20%
Drug Therapy
20%
Immunosuppressant
20%
Immunology
20%
Drug Toxicity
20%
Pharmacology, Toxicology and Pharmaceutical Science
Myasthenia gravis
100%
Cholinergic Receptor
40%
Diseases
20%
Immunotherapy
20%
Autoimmune Disease
20%
Pharmacotherapy
20%
Immunosuppressive Agent
20%
Autoantibody
20%
Drug Toxicity
20%
Keyphrases
Design Rational
20%